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ABSTRACT 
 
Chronic kidney disease (CKD) is featured by a progressive decline of kidney function and is mainly caused 
by chronic diseases such as diabetes mellitus and hypertension. CKD is a complex disease due to 
cardiovascular complications and high morbidity; however, there is no single treatment to improve kidney 
function in CKD patients. Since biological markers representing oxidative stress are significantly elevated in 
CKD patients, oxidative stress is receiving attention as a contributing factor to CKD pathology. Aim of our 
study is comparison of oxidant and anti oxidant parameters in chronic renal failure, Hemodialysis (pre and 
post) and control subjects. Materials and Methods: The present study was conducted on a patient group 
comprising of 50 patients diagnosed with CRF, 50 were pre hemodialysis, 50 were post hemodialysis (MHD). 
This patient group was compared to a healthy group including 100 controls. All the study participants were 
admitted in the department of Medicine [Nephrology department] at “Fathima Institute of Medical 
Sciences”, Kadapa. Andhra Pradesh. India. The obtained serum samples were used for biochemical analysis 
for estimating MDA, vitamin A and Glutathione Peroxidase (GPx). Conclusion: Our results reflects the 
primary mechanisms of oxidative stress and inflammation during hemodialysis which may cause of CVD 
development in hemodialysed patients. 
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INTRODUCTION 
The worldwide increase in the incidence of ESRD is 
clear. Diabetes mellitus remains the most common 
cause of ESRD worldwide, with an increasing 
percentage of individuals entering ESRD with this 
diagnosis every year. this is true in the United States 
where the percentage of patients with ESRD due to 
diabetes is almost 44%.in India 56%, in Jalisco, 
Mexico it is almost 57%, in malaysia 56%,in Japan 
38%. The pima Indians of Arizona tend to develop 
ESRD at a younger age and at an accelerated rate 
compared with other populations (1). 
Kidney disease manifests in many ways. A patient 
may be completely asymptomatic or may be 
desperately ill with a life treating emergency. A 
greater appreciation for the prevalence of chronic 
kidney disease in the population has led to 
improvements in identification and diagnosis of 
chronic kidney disease leading to progressive renal 
failure and end stage renal disease (2). 
 
Figure 1: Shows chronic renal failure causes neurologi-
cal damage 
Chronic Renal Failure (CRF) is a common health 
problem. patients with CRF most often present with 
nonspecific complications or are asymptomatic and 
are referred to a nephrologists because of abnormal 
blood or urine findings. the strongest factors 
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associated with increased risk for CKD are diabetes 
mellitus and hypertension (3). other clinical factors 
are autoimmune disease, chronic system infections, 
CVD, cancer, drug exposure and urinary track 
infection. CKD is an independent risk factor for 
cardiovascular disease and all cause mortality. 
The CRF patients who undergo to dialysis; are 
subjected to an oxidative stress, dialysis induced 
oxidative stress is one of the possible reason which 
creates atherosclerotic changes in hemodialysis 
patients. Over last few years, there has been 
increasing focus on the relationship of novel risk 
factors such as inflammation, oxidative stress, 
hyperhomocysteinemia, and high hs-CRP levels are 
associated with cardiovascular risk in CRF (3,4). 
Free radicals are highly reactive species 
characterized by an unpaired electron in their outer 
orbital. Free radical reactions, including lipid 
peroxidation, are considered to be important factors 
in the pathogenesis of a variety of diseases. Free 
radicals can damage proteins, lipids, carbohydrates 
and nucleic acids. Plasma membranes are critical 
targets of free radical reactions. Oxygen derived free 
radicals can easily produce injuries to cell 
membranes by initiation of polyunsaturated fatty 
acid peroxidation, inactivation of membrane 
enzymes and receptors and protein cross linking and 
fragmentation (5). 
 
Figure 2: Factors involved in the progression of kidney 
dysfunction in CKD and the role of NRF2. 
Increased concentration of Malondialdehyde (MDA)- 
an intermediate product of oxidation of 
polyunsaturated fatty acid – have been reported in 
the plasma and erythrocytes as well as in platelets 
and in mononuclear cells, of haemodialyzed patients 
(6). It has been observed that chronic renal failure is a 
pro-oxidant state, characterized by increased levels 
of free radical oxidants relative to antioxidants (7). 
However, thus far it is not clear whether increased 
MDA level is caused by the dialysis procedure or by 
the kidney disease itself. To defend themselves 
against these free radicals’ attack, cells have 
developed various antioxidant systems. Glutathione 
Peroxidase has four isoforms GSHPx-1 in red cells, 
GSHPx-2 in gastrointestinal mucosa, GSHPx-3 in 
blood plasma and the cell membrane located GSHPx-
4(8). These enzymes use the reducing power of 
glutathione to remove an oxygen atom from 
hydrogen peroxide and lipid hydro peroxide. Vitamin 
A is fat soluble and among the tocopherols alpha 
tocopherol is biologically the most active. it is an 
antioxidant present in all cellular membranes and 
protects against lipid peroxidation. Alpha tocopherol 
can directly act on oxy radicals and thus serves as an 
important chain breaking antioxidant (9-10).  
Aim of our study is comparison of oxidant and anti 
oxidant parameters in chronic renal failure, 
hemodialysis (pre and post) and control subjects. 
MATERIAL AND METHODS 
All the Patients were admitted in the department of 
Medicine [Nephrology department] at “Fathima 
Institute of Medical Sciences”, Kadapa. Andhra 
Pradesh. India. Present study were divided into four 
groups. 
• Group-I: healthy controls - 100. 
• Group-II –CRF Patients - 50. 
• Group-III: CRF patients on haemodialysis 
(Pre HD) -50. 
• Group-IV: CRF patients on haemodialysis 
(Post HD) - 50. 
The exclusion criteria were patients with no clinical 
or laboratory evidence of diabetes mellitus, liver 
diseases, lupus nephritis, acute illness, respiratory 
diseases. None of the patients had history of 
antioxidant drugs supplementation.  
The study was conducted after obtaining Institutional 
Ethical Committee clearance and informed consent 
was obtained from the study participants. Five ml of 
whole blood samples were drawn into plain tubes to 
obtain serum samples after centrifugation at 
4000rpm for 10 minutes. The obtained serum 
samples were used for biochemical analysis for 
estimating nitric oxide, oxi-LDL and Homocysteine 
levels. 
Statistical analysis 
All the values were expressed as mean and standard 
deviation (mean ± SD). The statistical analysis were 
done by using one way analysis of variance (ANOVA) 
using SPSS for windows version 11.5 (SPSS, Inc., 
Chicago). A p-value of <0.001 was considered to be 
statistically significant. 
RESULTS 
Laboratory data showed a significant change in the 
levels of biochemical parameters in CRF, pre and post 
hemodialysis groups in comparison to normal 
controls (Table I). All the data was presented as mean 
and standard deviation. P value of < 0.001 was 
considered statistically 
Significant. 
The Mean and standard deviation of plasma 
malondialdehyde showed significant difference 
between pre-dialysis and control group [p<0 .001]. It 
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was significantly increased in the pre-dialysis group 
when compared with CRF, Post dialysis and control 
group [p<0.001]. Pre Hemodialysis plasma MDA 
showed no significant rise when compared to post 
Haemodialysis level. And a significant rise when 
compared to control. 
The Mean and standard deviation of erythrocyte 
glutathione peroxidase activity [GPx] was 
significantly reduced in the post dialysis group when 
compared with CRF, pre dialysis and control group 
[p< 0.001.]. There was also a significant difference 
between pre dialysis and control group [p< 0.001]. 
The Mean and standard deviation of Vitamin A 
significantly reduced in the post dialysis group when 
compared with CRF, pre dialysis and control group 
[p< 0.001.]. There was also a significant difference 
between CRF, pre dialysis and control group [p< 
0.001]. 
Graph of all the investigations of this study were 
plotted by using the healthy controls - 100. CRF 
Patients -50.CRF patients on haemodialysis (Pre HD) 
-50. CRF patients on haemodialysis (Post HD) - 50. 
individual values of all investigations done in CRF Pre 
and Post HD and in control subjects. 
Table 1: Comparison of oxidant and anti oxidant pa-
rameters in CRF, HD (pre and post) and controls 
(Mean + SD) 










































Figure 3: Shows the values of MDA levels in CRF, Pre 
and Post HD and in control subjects. 
 
Figure 4: Shows the values of GPx levels in CRF, Pre 
and Post HD and in control subjects. 
 
Figure 5: Shows the values of Vitamin - A levels in 
CRF, Pre and Post HD and in control subjects. 
DISCUSSION 
In our present study the Mean and standard deviation 
of plasma malondialdehyde showed significant 
difference between pre-dialysis and control group 
[p<0 .001]. It was significantly increased in the pre-
dialysis group when compared with CRF, Post 
dialysis and control group [p<0.001].Pre 
Hemodialysis plasma MDA showed no significant rise 
when compared to post Haemodialysis level. And a 
significant rise when compared to control. The Mean 
and standard deviation of erythrocyte glutathione 
peroxidase activity [GPx] was significantly reduced in 
the post dialysis group when compared with CRF, pre 
dialysis and control group [p< 0.001]. The Mean and 
standard deviation of Vitamin A significantly reduced 
in the post dialysis group when compared with CRF, 
pre dialysis and control group [p< 0.001]. There was 
also a significant difference between CRF, pre dialysis 
and control group [p< 0.001] 
Inflammation plays an important role in the 
development and progression of most chronic kidney 
disease. The kidney itself at end stage is characterized 
historically in virtually all cases by hallmark of 
chronic inflammation, including infiltration by white 
blood cells and fibrosis. Markers of inflammation 
including C- reactive protein, interleukin 1 and 6 and 
tumor necrosis factor, are elevated in plasma of 
patients with CKD (11-12).  
Oxidative stress and inflammation recently came in 
focus as nonconventional risk factors of 
cardiovascular morbidity and overall mortality in end 
stage renal disease. Oxidative stress occurring due to 
decreased antioxidant defenses and an increase in 
pro-oxidant factors is a well recognized phenomenon 
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in hemodialysis patients(13). Hemodialysis is an 
effective treatment in most renal failure patients and 
forms an alternative to renal transplantation. 
Adequate dialytic treatment has prolonged the 
survival of patients with quality of life. 
Cardiovascular disease was found to be the most 
frequent cause of mortality in majority of patients on 
maintenance haemodialysis (14-15). 
Thus the results of our study shows that significant 
difference of antioxidant enzymes between pre and 
post dialysis group is thought to be related with the 
loss of antioxidant enzymes through the membrane 
and the decreased antioxidant enzymes may be 
related to increased of lipid peroxidation in 
hemodialysed patient. 
CONCLUSION 
Our results reflects the primary mechanisms of 
oxidative stress and inflammation during 
hemodialysis which may cause of CVD development 
in hemodialysed patients. Due to adverse effect of HD 
which is demonstrated by our results, the clinicians 
may plan to advice antioxidant therapy and use of 
antioxidant bounded membrane for HD will be new 
approach to over rule oxidative stress and 
inflammation during HD session. 
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